Leptin–STAT3–G9a signaling promotes obesity-mediated breast cancer progression

CC Chang, MJ Wu, JY Yang, IG Camarillo, CJ Chang - Cancer research, 2015 - AACR
CC Chang, MJ Wu, JY Yang, IG Camarillo, CJ Chang
Cancer research, 2015AACR
Obesity has been linked to breast cancer progression but the underlying mechanisms
remain obscure. Here we report how leptin, an obesity-associated adipokine, regulates a
transcriptional pathway to silence a genetic program of epithelial homeostasis in breast
cancer stem–like cells (CSC) that promotes malignant progression. Using genome-wide
ChIP-seq and RNA expression profiling, we defined a role for activated STAT3 and G9a
histone methyltransferase in epigenetic silencing of miR-200c, which promotes the formation …
Abstract
Obesity has been linked to breast cancer progression but the underlying mechanisms remain obscure. Here we report how leptin, an obesity-associated adipokine, regulates a transcriptional pathway to silence a genetic program of epithelial homeostasis in breast cancer stem–like cells (CSC) that promotes malignant progression. Using genome-wide ChIP-seq and RNA expression profiling, we defined a role for activated STAT3 and G9a histone methyltransferase in epigenetic silencing of miR-200c, which promotes the formation of breast CSCs defined by elevated cell surface levels of the leptin receptor (OBRhi). Inhibiting the STAT3/G9a pathway restored expression of miR-200c, which in turn reversed the CSC phenotype to a more differentiated epithelial phenotype. In a rat model of breast cancer driven by diet-induced obesity, STAT3 blockade suppressed the CSC-like OBRhi population and abrogated tumor progression. Together, our results show how targeting STAT3-G9a signaling regulates CSC plasticity during obesity-related breast cancer progression, suggesting a novel therapeutic paradigm to suppress CSC pools and limit breast malignancy. Cancer Res; 75(11); 2375–86. ©2015 AACR.
AACR